Short Interest in Hypermarcas (OTCMKTS:HYPMY) Grows By 12,687.5%

Hypermarcas (OTCMKTS:HYPMY) was the recipient of a large increase in short interest during the month of June. As of June 30th, there was short interest totaling 2,046 shares, an increase of 12,687.5% from the June 15th total of 16 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average daily volume of 33,339 shares, the days-to-cover ratio is presently 0.1 days.

Hypermarcas Trading Up 3.3%

HYPMY traded up $0.13 during trading on Friday, hitting $4.09. 2,969 shares of the company’s stock traded hands, compared to its average volume of 20,966. The stock has a market capitalization of $2.88 billion, a price-to-earnings ratio of 8.52 and a beta of 0.71. The company’s 50 day simple moving average is $4.28 and its two-hundred day simple moving average is $4.39. Hypermarcas has a 12-month low of $3.71 and a 12-month high of $5.50.

Hypermarcas (OTCMKTS:HYPMY) last announced its quarterly earnings results on Wednesday, April 29th. The company reported $0.10 earnings per share (EPS) for the quarter. Hypermarcas had a return on equity of 14.08% and a net margin of 19.41%.The firm had revenue of $383.13 million for the quarter. On average, equities analysts expect that Hypermarcas will post 0.53 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded shares of Hypermarcas to a “hold” rating in a research note on Wednesday, April 29th. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, Hypermarcas currently has an average rating of “Buy”.

Hypermarcas Company Profile

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.